Innoveren Scientific
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
-80.00
$1.52M
2
Innoveren Scientific, Inc. is a hybrid-biopharmaceutical company. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2014-12-19. The firm is focused on advancing technologies in areas of unmet need across multiple indications for improving patient lives. Its product pipeline includes SkinDisc Lite, SkinDisc, and BreathEasy. From a single application, SkinDisc provides an active cellular matrix that maintains complete full wound contact and depth fill during the healing process, resulting in rapid growth of the host tissue. The SkinDisc product achieves healing in four to nine weeks. BreatheEasy is a 510(k) De Novo pathway medical device that is an autologous IV infusion that helps patients struggling with COPD, as well as other closely related diseases, such as chronic bronchitis and emphysema.
Innoveren Scientific, Inc. is a hybrid-biopharmaceutical company. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2014-12-19. The firm is focused on advancing technologies in areas of unmet need across multiple indications for improving patient lives. Its product pipeline includes SkinDisc Lite, SkinDisc, and BreathEasy. From a single application, SkinDisc provides an active cellular matrix that maintains complete full wound contact and depth fill during the healing process, resulting in rapid growth of the host tissue. The SkinDisc product achieves healing in four to nine weeks. BreatheEasy is a 510(k) De Novo pathway medical device that is an autologous IV infusion that helps patients struggling with COPD, as well as other closely related diseases, such as chronic bronchitis and emphysema.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.